טוען...
Glutamate-cysteine ligase catalytic subunit is associated with cisplatin resistance in lung adenocarcinoma
BACKGROUND: Cisplatin is a key drug for treating lung adenocarcinoma, and its sensitivity to cisplatin is directly related to prognosis. We aimed to reveal the roles of genes related to glutathione synthesis (glutamate-cysteine ligase catalytic subunit, GCLC) and cystine uptake (cystine/glutamate tr...
שמור ב:
| הוצא לאור ב: | Jpn J Clin Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5892860/ https://ncbi.nlm.nih.gov/pubmed/29474642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyy013 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|